Steve Tutewohl - Jul 8, 2021 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
Chief Operating Officer
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Stock symbol
EVH
Transactions as of
Jul 8, 2021
Transactions value $
-$1,742
Form type
4
Date filed
7/12/2021, 04:59 PM
Previous filing
Jul 2, 2021
Next filing
Jul 13, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Options Exercise $2.66K +200 +0.18% $13.29 114K Jul 8, 2021 Direct F1, F2
transaction EVH Class A Common Stock Sale -$4.4K -200 -0.17% $22.00 114K Jul 8, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVH Class A Common Stock Option (right to buy) Options Exercise $0 -200 -0.93% $0.00 21.4K Jul 8, 2021 Class A Common Stock 200 $13.29 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021.
F2 Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F3 The Class A Common Stock Options exercised vested on March 1, 2020.